AlphaMark Advisors, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 81 filers reported holding MIRATI THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.12 and the average weighting 0.8%.

Quarter-by-quarter ownership
AlphaMark Advisors, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$52,000
+67.7%
4000.0%0.02%
+69.2%
Q3 2019$31,000
-24.4%
4000.0%0.01%
-27.8%
Q2 2019$41,000
+41.4%
4000.0%0.02%
+50.0%
Q1 2019$29,000
+70.6%
4000.0%0.01%
+50.0%
Q4 2018$17,000
-10.5%
4000.0%0.01%0.0%
Q3 2018$19,000
-40.6%
400
-38.5%
0.01%
-38.5%
Q2 2018$32,000
+60.0%
6500.0%0.01%
+44.4%
Q1 2018$20,000
-13.0%
650
-48.0%
0.01%0.0%
Q4 2017$23,000
+91.7%
1,250
+25.0%
0.01%
+80.0%
Q3 2017$12,0001,0000.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders